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Abstract
Background: An education self-management program for people with osteoarthritis (OA) of the
knee was designed to be delivered by health professionals, incorporating their knowledge and
expertise. Improvement in quality of life, health status and pain in response to this program has
previously been demonstrated in an uncontrolled pilot study. To more rigorously test the
effectiveness of the program we will undertake a randomised controlled trial of people with OA of
the knee offering specific self-administered exercises and education, in accordance with the
principles of self-management.
Aim: To determine whether an education self management program for subjects with
Osteoarthritis (OA) of the knee (OAK program) implemented by health professionals in a primary
health care setting can achieve and maintain clinically meaningful improvements compared standard
medical management in a control group.
Methods: The effects of standard medical management will be compared with the effects of the
OAK program in a single-blind randomized study.
Participants:  146 male and female participants with established OA knee will be recruited.
Volunteers with coexistent inflammatory joint disease or serious co-morbidities will be excluded.
Interventions: Participants will be randomized into either intervention or control groups (delayed
start). The intervention group will complete the OA knee program and both groups will be
followed for 6 months.
Measurements: Assessments will be at baseline, 8 weeks and 6 months. SF-36, WOMAC and VAS
pain questionnaires will be completed. Isometric quadriceps and hamstring strength will be
measured using a dynamometer; knee range of movement using a goniometer; and physical function
will be determined by a modified timed up and go test. Data will be analysed using repeated
measures ANOVA.
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Discussion: While there is evidence to support the effectiveness of SM programs for people with
hypertension, diabetes and asthma, the evidence available for treatment of arthritis remains
equivocal. The aim of this study is to determine the effectiveness of a disease specific self-
management program for people with OA knee.
The study design includes all the important features of a clinical experimental study to minimize
bias so the results of the study will provide a high level of evidence. People with OA of the knee
have identified pain and problems with daily activities as the most important problems associated
with their condition. The outcome measures selected specifically address these issues and have
demonstrated validity and are responsive within the range of change expected in response to the
intervention. Hence the results of the study will reflect their priorities.
The results of the study will provide evidence to guide clinicians and funding bodies seeking to
establish priorities regarding the provision of this disease specific program.
Trial registration: ACTR number: 12607000080426
Background
Self-management is a primary care intervention that has
become a popular component of management in a
number of chronic conditions including arthritis. Unlike
traditional patient education programs, self-management
programs aim to achieve more than the provision of infor-
mation to increase knowledge. They also aim to change
health behavior and health status, teaching patients to
identify and solve problems, set goals and plan actions
[1].
Numerous self-management programs have been devel-
oped for different health conditions. Various models have
been employed including individual and group-based
programs that may be disease specific or generic [2]. Face-
to-face interaction with health professionals is an impor-
tant component of some programs, whereas trained lay
leaders, usually presenting scripted information, deliver
others.
There is a considerable body of research evaluating self-
management programs. Reviews and meta-analyses [3,4]
have shown that patient self-management education pro-
grams can significantly improve knowledge, compliance
behaviours, and health outcomes, however the effective-
ness differs between programs and disease states.
One systematic review of self-management interventions
for a number of chronic diseases, found a trend towards a
small benefit from arthritis programs, but the results were
not significant and there was a suggestion of publication
bias [2]. Many of the existing arthritis self-management
programs are designed to cater for participants with any
form of arthritis. Examples of this approach are the
Chronic Diseases and Arthritis Self-Management pro-
grams (ASMP) developed at Stanford University [5,6].
These programs are also delivered in a group setting but
they are led by trained lay tutors. They have a more generic
approach as they are catering for participants with a vari-
ety of different musculoskeletal diseases in the one group.
This approach may be cheaper to deliver but cost-effec-
tiveness is yet to be established [7,8].
The ASMP has been tested widely with the majority of
studies conducted in the USA or UK. Many, but not all of
these studies have found the program to be effective.
Overall, Warsi et al (2004), in their systematic review of
self-management interventions for various chronic dis-
eases, found a trend towards a small benefit from arthritis
programs, the majority being ASMP or ASMP derivatives,
but the results were not significant and here too it was sug-
gested that there was publication bias [2].
We hypothesised that a program designed for a specific
diagnostic group may be more effective. We considered a
program of this nature would be justified for more preva-
lent conditions such as osteoarthritis of the knee.
Accordingly, we developed a self-management program
for people with osteoarthritis of the knee. The program
was designed to be delivered by health professionals.
Strategies for pain management; the benefits of different
types of exercise (strength, aerobic, flexibility, balance);
and approaches for falls prevention were included. In
keeping with a social cognitive theory approach, individ-
ual problem identification, goal setting and action plan-
ning were encouraged to facilitate improvements in self-
efficacy. This program was tested in an uncontrolled qual-
ity assurance study. The results indicated improvement in
pain, quality of life and physical function [9]. The purpose
this study was to more rigorously test the program in a
randomized controlled study.BMC Musculoskeletal Disorders 2008, 9:133 http://www.biomedcentral.com/1471-2474/9/133
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Methods
Aim
To compare the effectiveness of an osteoarthritis of the
knee self-management education program delivered by
health professionals with a control group, as determined
by improvements in pain, quality of life and physical
function.
Study Design
A two group randomized, controlled repeated measures
study design will compare the osteoarthritis of the knee
program (OAK) with a similar group of control partici-
pants. Independently of the study all participants will be
able to receive standard medical management of OA knee.
In addition, the intervention group will participate in a
disease specific knee osteoarthritis self-management pro-
gram (OAK). Blinding of participants will not be possible
due to the nature of the intervention; however, assessors
will be blinded to group allocation. The OAK program
will be conducted in a community setting at Arthritis
Western Australia.
Hypothesis
People with osteoarthritis of the knee who complete the
OAK Program will report improved quality of life,
improved knee function and decreased pain compared
with those managed conventionally.
Ethical Issues
This study has been approved by the Human Research
Ethics Committee at Curtin University of Technology
(HR141, 2002). All participants will provide written
informed consent prior to randomisation. Data access and
storage will be in keeping with National Health and Med-
ical Research Council guidelines, as approved. License
agreements have been obtained for SF-36 Questionnaire
and WOMAC Questionnaire. This trial is registered with
the Australian and New Zealand Clinical Trial Registry,
number: 12607000080426.
Subjects
146 participants with established OA of one or both knees
will be recruited into the study. As the OAK program is
generally provided as a clinical service, subjects will be
recruited from among people presenting to enroll in the
OAK program. The operational definition for OA knee is
diagnosis by a medical practitioner based on either clini-
cal examination or radiological evidence. Disease severity
is not a selection criterion. Exclusion criteria will be rheu-
matoid arthritis or other inflammatory joint disease; knee
surgery planned within 6 months of commencing the
study; physical impairments that preclude full participa-
tion; inability to communicate in English within a group
setting or aged ≤ 18 years (Table 1). During the recruit-
ment phase the program will be actively promoted to gen-
eral practitioners and rheumatologists through
professional societies, and to the general public through
advertising and media coverage.
Volunteers for the study will be randomized to an inter-
vention group (immediate start) or a control group
(delayed start). As there is evidence that SM is an effective
addition to usual care [5,10], all volunteers randomized
to the control group will be offered the intervention at the
completion of the 6-month control period.
Group allocation
Volunteers will be randomized in blocks to ensure man-
ageable numbers for intervention groups. Pre-prepared
cards indicating group assignment will be placed in sealed
opaque envelopes and drawn as a lottery by a third party
for allocation to treatment groups. In order to ensure opti-
mum group sizes, allocation will not take place until a
whole block has been recruited
Intervention
The OAK program will be conducted over a 6-week period
enabling participants to incorporate and consolidate
information learned from week to week. In addition to
the weekly sessions, participants will be given printed
information relevant to the course component discussed
each week. Program leaders will be health professionals
including nurses, physiotherapists, and occupational ther-
apists that have the knowledge and skills to present infor-
mation on disease specific topics and accurately respond
to complex questions. It is necessary that health profes-
sionals who deliver this program meet minimum muscu-
loskeletal knowledge requirements. The fidelity of the
OAK program will be maintained by the use of a facilita-
Table 1: Eligibility criteria
Inclusion criteria Exclusion criteria
English speaking Co-existing inflammatory arthritis
Aged 18 years or over Serious co-morbidity
Diagnosis of OA (X-Ray or clinical Dx) Scheduled knee replacement in < 6 months
Referral from GP or Specialist Cannot meet program time-points
Able to meet program requirementsBMC Musculoskeletal Disorders 2008, 9:133 http://www.biomedcentral.com/1471-2474/9/133
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tor's manual with modules for program delivery each
week.
To facilitate optimum group dynamics, the target group
size will be 12 participants, although this may vary from
8 to 16 depending on recruitment and randomisation.
The program approach is holistic and will not exclusively
focus on one aspect of care. Self-management constructs
will be employed to promote behavioral changes that will
be aimed at optimizing participants' health status. Goal
setting and the development of strategies to achieve these
goals long term [11] will be emphasized in the program.
Participants will be encouraged to set their own goals
related to health areas that they identify as requiring
improvement.
Topics that will be covered in the weekly sessions include:
• Pain management strategies (cognitive and pharmaceu-
tical)
￿ Joint protection
￿ Fitness/exercise
￿ Correct use of analgesia/medications
￿ Balance/falls prevention/proprioception
￿ Cognitive techniques
￿ Pathophysiology
￿ Nutrition/weight control
￿ Self-management skills
￿ Team approach to health care
￿ SMART goals (Specific, Measurable, Achievable, Realis-
tic, Time-framed)
Assessments and Procedures
Assessments will be performed by 2 physiotherapists
blinded to group allocation; conducted one week prior to
the first self-management session (baseline) and on the
week following the sixth and final session (week 8). The
physiotherapists performing assessments will have no
contact with the participants other than during the assess-
ment sessions and will not participate in facilitation of the
program. Participants will be assessed by the same physi-
otherapist whenever possible to ensure consistency.
Members of the control group will also attend assess-
ments at baseline, and week 8. All volunteers will be
assessed again 6 months after randomisation. In keeping
with intention to treat principles, all participants will be
encouraged to attend for follow-up measurements regard-
less of level of attendance at the self-management inter-
vention. Self reported questionnaires (WOMAC, SF-36,
VAS pain) would be mailed out to participants that are
unable to attend assessment visits. Program and assess-
ment attendance (at all time-points) will also be collected
and collated.
Demographic information will include age, sex, co-mor-
bidities and socioeconomic information. Socio-economic
scales will be compiled using "The Index of Relative Socio-
Economic Disadvantage" scales [12]. This index provides
a weighted value that includes variables that reflect or
measure disadvantage. These variables include: low-
income, low educational attainment, high unemploy-
ment and low skilled occupations.
The dependent variables for the study are listed below.
Primary outcomes
￿ Health status; measured using the WOMAC Osteoarthri-
tis Index for OA of the knee (WOMAC LK3.0). Also self-
administered, the WOMAC assesses pain, stiffness and
physical function [13] and can be completed in less than
5 minutes. Two major studies have shown WOMAC pain,
stiffness and physical function subscales are valid and the
questionnaire is reliable and sensitive enough to detect
changes in health status following a variety of interven-
tions [14,15]
￿ Quality of life; measured using the Short Form 36v1 (SF-
36) questionnaire. This 36 item questionnaire is self
administered, and can be completed in about 15 minutes
[16]. Scores for 8 sub components reflecting both physical
and mental status can be generated. Reliability and valid-
ity have been established in numerous studies [16,17].
Secondary outcomes
￿ Active range of motion of the knee joints; measured
using a long armed Goniometer [18]. The reliability and
validity of the goniometer to measure range of motion has
been widely documented for knee flexion and extension
[18,19].
￿ Strength of the hamstrings and quadriceps muscles will
be measured using a Mecmesin Force Gauge Dynamome-
ter. The dynamometer will be fixed via an adjustable arm
to a portable steel frame and stool. Subjects will sit on the
stool with hips and knees flexed to 90 degrees. Isometric
strength in flexion and extension will be measured in this
position. Each knee will be measured 3 times. The first
measurement will be a practice and will be excluded fromBMC Musculoskeletal Disorders 2008, 9:133 http://www.biomedcentral.com/1471-2474/9/133
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analysis. The two subsequent measures will be averaged
for analysis.
￿ Pain will be assessed at weekly intervals from baseline to
the 8-week follow-up assessment. (See Figure 1: Study
Design Flow Chart). A 10 cm Visual Analog Scale (VAS)
anchored at the left with "no pain" and at the right "worst
pain imaginable" will be used for this assessment. The
VAS is well established in clinical practice and research for
measuring pain levels in arthritis populations [20].
￿ Functional mobility, using a Functional Knee Assess-
ment Test (FKAT) will be assessed using a modification of
the "Timed Up and Go" test (TUG). TUG is widely used to
assess basic functional mobility in the elderly [21-23]. The
test measures the time taken to stand from a chair and
walk 6 m, turn around, return to the chair and sit down.
For this study the addition of ascending and descending a
15 cm step will be added to the outward walk.
Statistical Power Calculation
A priori power calculations for this study will be based on
the quality of life outcome as measured by the SF-36.
Sample size was calculated according to guidelines in the
SF-36 Users Manual to determine differences in changes
over time between the intervention and control groups
using a repeated measures design allowing an inter tem-
poral correlation between scores of 0.60 [16]. The pilot
study SF-36 data showed an average improvement of 10
points across the eight domains measured. Assuming this
level of improvement is achieved in the intervention
group and there is no change in the control group and
allowing for a 10% drop out rate, the number of partici-
pants required per group will be 60 [16]. In the pilot
study, there was a drop out rate of 5% over 3 years, so
allowing 10% is a conservative estimate. Differences in
changes in functional ability measured using the
WOMAC, similar in magnitude to those previously docu-
mented [24] would also be detectable in a sample of this
size.
Study Design Flow Chart Figure 1
Study Design Flow Chart.
Control group Intervention group
Randomisation
n=146
Baseline
assessment
Week 8
assessment
6-month
assessment
6-month
assessment
Week 8 assessment
Baseline
assessment
6 Week OAK S-M
programBMC Musculoskeletal Disorders 2008, 9:133 http://www.biomedcentral.com/1471-2474/9/133
Page 6 of 7
(page number not for citation purposes)
Data Analysis
Data will be analyzed in a blinded manner. Treatment
groups will be examined for comparability at baseline.
Main comparisons between treatment groups will be per-
formed using an intention to treat analysis. To test the
effects of treatment, between group differences in changes
over time will be examined using repeated measures
ANOVA. Separate analysis will be conducted for each out-
come variable. Statistical significance will be inferred at a
2-tailed p < 0.05. Results will not be adjusted for multiple
comparisons as all outcomes of interest have been nomi-
nated a priori and such adjustment would likely render all
findings of interest, despite their clinical importance, non-
significant.
Discussion
Self-management aims to motivate people to undertake
the changes in behavior necessary to improve their lives.
The preference of patients to actively manage their condi-
tion themselves is well matched to the aim of the multi-
disciplinary SM program to empower people to manage
their condition [25]. People with OA of the knee have
identified pain and problems with daily activities as the
most important problems associated with their condition.
Hence the results of the study will reflect their priorities.
The outcome measures selected have demonstrated valid-
ity and are responsive within the range of change expected
in response to the intervention.
This disease specific self-management program differs
from other more generic arthritis programs. Using the
skills and expertise of health professionals in a program
providing disease specific education and self-manage-
ment will provide a platform for behavior change that is
not feasible with the limited knowledge base of lay lead-
ers. The outcome measures are designed to reflect positive
changes in pain, knee function and quality of life (inter-
vention group), compared with those participants that are
managed with conventional treatment (control group).
The study design compares the OAK program with the
usual management of people with OA in the community.
Randomisation to treatment or no treatment groups pre-
vents conscious or unconscious bias [26]. Although blind-
ing of group participants is not possible, the
physiotherapists assessing outcome measures will be
blinded to group allocation to minimize potential bias
[27]. Using an intention to treat design will reflect the way
the treatment will perform in the community and reduces
the potential bias of drop out or non-compliant partici-
pants.
There is insufficient evidence to unequivocally claim that
self-management is an effective treatment for osteoarthri-
tis of the knee. The results of the study will provide evi-
dence to guide clinicians and funding bodies to establish
priorities regarding the provision of this disease specific
program.
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